CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE
- Status
- RECRUITING
- Phase
- NA
Community-based Behavioral Intervention to Increase Vaccination Using MOST
- Status
- WITHDRAWN
- Phase
- PHASE2
The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications
- Status
- COMPLETED
- Phase
- PHASE2
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
- Status
- COMPLETED
- Phase
- NA
Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease
- Status
- COMPLETED
- Phase
- NA
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
- Status
- RECRUITING
- Phase
- PHASE2
Influenza Reminder Text-Messaging
- Status
- COMPLETED
- Phase
- NA
Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza
- Status
- RECRUITING
- Phase
- PHASE3
Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza
- Status
- RECRUITING
- Phase
- PHASE3
Immunogenicity of Influenza Vaccinations
- Status
- COMPLETED
- Phase
- PHASE4
A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older
- Status
- COMPLETED
- Phase
- PHASE1
Pooled Analysis of Methodologically Harmonized Pragmatic Randomized Trials of High-Dose vs. Standard-Dose Influenza Vaccine Against Severe Clinical Outcomes
- Status
- COMPLETED
- Phase
- PHASE4
Revealing Protective Immunity to Influenza Using Systems Immunology
- Status
- COMPLETED
- Phase
- PHASE4
Effectiveness of SMS Nudging to Increase Coverage of Influenza Vaccination Among the Elderly
- Status
- NOT_YET_RECRUITING
- Phase
- NA